Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLEASE Persistent Lyme Empiric Antibiotic Study Europe
2009-010939-40Phase 4Completed
- Sponsor
- Radboud University Medical Center
- Start
- Jul 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ceftriaxone, doxycycline, clarithromycin and hydroxychloroquine in Lyme borreliosis (3 arms), sponsored by Radboud University Medical Center. Primary endpoints: Mean functional impairment at end of treatment and Mean pain score at end of treatment. Started Jul 2009; status: completed.
02
Drugs
ceftriaxonedoxycyclineclarithromycinhydroxychloroquine
03
Conditions
Lyme borreliosis
Beyond the preview
Go deeper on 2009-010939-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010939-40.